top of page

Cardiovascular

Health

CardioMetabolic 

Health

Lung Health

Bone Health

All-in-one AI-CVD

497e6f54-782b-4e077a-3a7144e4f3e4.png

AutoFracture

(coming soon)

upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
0bdba309-a76a-4215-b207-90a7932bb681.png
iScreen Shoter - 20260520111737117 1.png
Frame 1000004271.png
iScreen Shoter - 20260520105243724 1.png
iScreen Shoter - 20260520105243724 1.png
iScreen Shoter - 20260520100645073 1.png

1 Non-Contrast Scan              10+ Actionable Reports

What if a routine coronary artery calcium scan could see aortic stenosis risk before symptoms?

  • 3 days ago
  • 1 min read

Updated: 23 hours ago


ESC 2026 · 10 Scientific Presentations · Oral & Poster · 7/10

 

One CT. 25 automated phenotypes. Nearly two decades of follow-up.



Aortic stenosis is often recognized only after obstruction or myocardial damage has already developed. But could information already captured in a routine noncontrast cardiac CT help identify risk much earlier?'

 

In a new HeartLung.AI scientific poster at ESC Congress 2026, researchers explored whether AI-CVD-derived imaging phenotypes could predict incident aortic stenosis long before clinical recognition.


The study included 5,520 MESA participants, with 157 incident cases of aortic stenosis over approximately two decades. AI-CVD automatically evaluated 25 imaging measures—including valvular and vascular calcification, cardiac chamber structure, adipose tissue, muscle, and bzone.

 

The results

 

The AI-CVD-AS model achieved:

 

0.973 AUROC for 10-year discriminationvs. 0.809 for the clinical model

Among the strongest imaging predictors were:

  • Aortic valve calcification (AVC)

  • Mitral valve calcification (MVC)

  • Thoracic aortic calcification (TAC)

  • LV mass index

  • AI-derived coronary artery calcium

     

A simple five-variable model using age, sex, AVC, MVC, and TAC substantially outperformed the clinical model.


These findings suggest automated phenotyping of routine noncontrast cardiac CT may offer an opportunity for earlier, opportunistic assessment of aortic stenosis risk - without requiring an extensive clinical risk-factor panel.

External validation and recalibration are required before clinical implementation.


📍 To be presented at ESC Congress 2026 · Munich

By Zahra Heidari Meybodi M.D.





Comments


Ready to Unlock the Value in Your CT Scans?

Join leading healthcare providers using AI-CVD to save lives and increase revenue, and lead the future of preventive cardiology.

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Youtube

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

aicvd patent_edited_edited.jpg
ISO LOGO_edited.png

©2026 HeartLung Corporation. All Rights Reserved. US Patent Nos US9119590*, US10695022, US11610686, US18167691, US20240115224, and Patents Pending. AI-CVD, AI-CAC, AutoBMD, AutoCAC, AutoChamber and other trademarks shown on this website are protected under intellectual property rights of HeartLung Corporation in the United States.

bottom of page